Search Results - Ebelin, M.-E.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

    Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients by Allen, B R, Lakhanpaul, M, Morris, A, Lateo, S, Davies, T, Scott, G, Cardno, M, Ebelin, M-E, Burtin, P, Stephenson, T J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles

    Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles by DE BRUGEROLLE DE FRAISSINETTE, A, PICARLES, V, ROSDY, M, DE WEVER, B, ETTLIN, R. A, CORDIER, A, CHIBOUT, S, KOLOPP, M, MEDINA, J, BURTIN, P, EBELIN, M. E, OSBORNE, S, MAYER, F. K, SPAKE, A

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Pharmacokinetic and pharmacodynamic data and models in clinical trials

    Pharmacokinetic and pharmacodynamic data and models in clinical trials by STEIMER, J.-L, EBELIN, M.-E, VAN BREE, J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products

    Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products by Medina, Jesús, de Brugerolle de Fraissinette, Anne, Chibout, Salah-Dine, Kolopp, Maryelle, Kammermann, Rahel, Burtin, Pascale, Ebelin, Marie-Eve, Cordier, A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis - A Multicenter, 3-Week, Open-Label Study

    Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis - A Multicenter, 3-Week, Open-Label Study by Staab, Doris, Pariser, David, Gottlieb, Alice B., Kaufmann, Roland, Eichenfield, Laurence F., Langley, Richard G., Scott, Graham, Ebelin, Marie-Eve, Barilla, Denise, Schmidli, Heinz, Burtin, Pascale

    Published in Pediatric dermatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple Oral administration

    Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple Oral administration by SCOTT, Graham, OSBORNE, Stuart A, GREIG, Gerard, HARTMANN, Stefan, EBELIN, Marie-Eve, BURTIN, Pascale, RAPPERSBERGER, Klemens, KOMAR, Michael, WOLFF, Klaus

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Low systemic concentrations of SDZ ASM 981 after topical treatment of extensive atopic dermatitis lesions

    Low systemic concentrations of SDZ ASM 981 after topical treatment of extensive atopic dermatitis lesions by Van Leent, E.J.M., Ebelin, M.-E., Burtin, P., Spuls, P.I., Bos, J.D.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: